Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00650585 · ClinicalTrials.gov registry record · NA
An Effectiveness Trial of Project ALERT
A NA study, sponsored by Pacific Institute for Research and Evaluation.
- Completed
- Registry status
- NA
- Development phase
- 8,338
- Enrollment target
NCT00650585: Completed NA study, sponsored by Pacific Institute for Research and Evaluation.
NCT00650585 is a NA study that has completed, run by Pacific Institute for Research and Evaluation. The registered enrollment target is 8,338 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (494% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00650585, a NA study, has completed, sponsored by Pacific Institute for Research and Evaluation.
- COMPLETED
- Registry status
- NA
- Development phase
- 8,338 participants
- Enrollment target
Study Summary
The purpose of this study is to replicate a longitudinal evaluation of Project ALERT, a substance abuse prevention program that targets middle school students.
Primary Outcome
Students completed an 81-item self-report questionnaire. They were asked on how many days they had used alcohol in the previous 30 days. Response options included "none," "1 or 2 days in the last month," "3 to 5 days in the last month," "6 to 19 days in the last month," and "20 or more days in the last month." Response options were dichotomized into none and at least one day.
Interventions
- BEHAVIORAL Project ALERT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,338 participants |
| Start Date | 2004-05 |
| Est. Completion | 2008-06 |
| Phase | NA |
What the finished NCT00650585 record still lists
NCT00650585 is an interventional study that assigns participants to a tested intervention. Its 8,338 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (494% higher).
The record links to 0 conditions, and to 1 intervention - of which Project ALERT is the first listed.
NCT00650585 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00650585 about?
NCT00650585 is a clinical study titled "An Effectiveness Trial of Project ALERT". The purpose of this study is to replicate a longitudinal evaluation of Project ALERT, a substance abuse prevention program that targets middle school students.
What is the current status of trial NCT00650585?
This trial is currently completed. It is a NA study. The enrollment target is 8,338 participants. The study started on 2004-05. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00650585?
The interventions under investigation include: Project ALERT (BEHAVIORAL).
Who is sponsoring clinical trial NCT00650585?
This trial is sponsored by Pacific Institute for Research and Evaluation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00650585's enrollment target sits among peer trials
8,338 18th of 2000 higher than 1,983 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07185828 · 8,286 participants · NA
Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)
- NCT06435806 · 8,200 participants · NA
Medical Illustration Design Characteristic Evaluation
- NCT06184945 · 8,100 participants · NA
Behavioral Economic & Staffing Strategies in the ICU
- NCT06098079 · 8,600 participants · Phase 4
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia